• ABOUT US
  • TECHNOLOGY
  • BUSINESS
  • R&D
  • IR
  • PR
  • RECRUIT
  • ENG
  • KOR

ABOUT US

  • Greeting from the CEO
  • Vision & Mission
  • History
  • Partners

TECHNOLOGY

  • Core Technology
  • Multi-Omics
  • Microbiome
  • Metabolome

BUSINESS

  • Personalized Analysis Service
  • Health Functional Food
  • CDO(GMP)

R&D

  • Research Institute
  • Patents and Papers
  • Pharmabiotic(LBP)
  • Pipeline

IR

  • Announcements
  • Inquiries and Suggestions

PR

  • Notice
  • Media

RECRUIT

  • Talents
  • Welfare
  • Employment Notice
  • Employment FAQ
  • PMAS
  • MBR
  • Multi-Omics Research
  • NGS
  • Analysis of Metabolome
  • Management of Microbial Resource
  • Research on Development of New Drugs

A microbiome healthcare company serving the value of healthy life

  • ABOUT US
    • Greeting from the CEO
    • Vision & Mission
    • History
    • Partners
  • TECHNOLOGY
    • Core Technology
      • PMAS
      • MBR
    • Multi-Omics
      • Multi-Omics Research
    • Microbiome
      • NGS
    • Metabolome
      • Analysis of Metabolome
  • BUSINESS
    • Personalized Analysis Service
    • Health Functional Food
    • CDMO(GMP)
  • R&D
    • Research Institute
    • Patents and Papers
    • Pharmabiotic(LBP)
      • Management of Microbial Resource
      • Research on Development of New Drugs
    • Pipeline
  • IR
    • Announcements
    • Inquiries and Suggestions
  • PR
    • Notice
    • Media
  • RECRUIT
    • Talents
    • Welfare
    • Employment Notice
    • Employment FAQ
  • 카카오톡
  • 네이버 블로그
  • 네이버 쇼핑
  • 인스타그램
  • 유튜브

A microbiome healthcare company serving the value of healthy life

  • ABOUT US
    • Greeting from the CEO
    • Vision & Mission
    • History
    • Partners
  • TECHNOLOGY
    • Core Technology
      • PMAS
      • MBR
    • Multi-Omics
      • Multi-Omics Research
    • Microbiome
      • NGS
    • Metabolome
      • Analysis of Metabolome
  • BUSINESS
    • Personalized Analysis Service
    • Health Functional Food
    • CDMO(GMP)
  • R&D
    • Research Institute
    • Patents and Papers
    • Pharmabiotic(LBP)
      • Management of Microbial Resource
      • Research on Development of New Drugs
    • Pipeline
  • IR
    • Announcements
    • Inquiries and Suggestions
  • PR
    • Notice
    • Media
  • RECRUIT
    • Talents
    • Welfare
    • Employment Notice
    • Employment FAQ
  • 카카오톡
  • 네이버 블로그
  • 네이버 쇼핑
  • 인스타그램
  • 유튜브

  • home
    • ABOUT US
    • TECHNOLOGY
    • BUSINESS
    • R&D
    • IR
    • PR
    • RECRUIT

Media

  • 에이치이엠파마, 지요셉 대표 글로벌 기업 암웨이 '과학자문위원' 선정
    2025.04.16
  • 에이치이엠파마, 엑셀세라퓨틱스와 바이오 신소재 연구 업무협약 체결
    2025.03.12
  • 올 日 맞춤형 마이크로바이옴 시장 공략…생균 치료제 CDO 키워 캐시카우로
    2025.03.11
  • 에이치이엠파마, 파이토바이옴 수출 본격화…암웨이와 글로벌 확장 가속
    2025.03.04
  • 한국바이오협회, 마이크로바이옴 신약기업협의회 정기총회 개최
    2025.02.27
  • 에이치이엠파마-경희대병원, 염증성 장질환 조기 진단 바이오마커 규명
    2025.02.26
  • 에이치이엠파마, 지난해 사상 최대 매출액 달성…전년比 182% 성장
    2025.02.14
  • 에이치이엠파마 "장내 미생물 연구로 저속노화와 비만 치료 부작용 개선"
    2025.01.09
  • 에이치이엠파마, 글로벌 암웨이 ‘과학적 협업’ 파트너 공식 지정
    2024.12.18
  • 에이치이엠파마, 하버드의대와 AI 활용 마이크로바이옴 플랫폼 구축
    2024.12.10
  • 에이치이엠파마, 세종시에 신규시설투자…“매출ㆍR&D 역량 확대”
    2024.11.29
  • 에이치이엠파마 "빌 게이츠도 인정한 마이크로바이옴, 세계 최대 데이터 확보"
    2024.11.22
1 2 3 4 5
Pohang
Address. 102, Business incubator center, Handong Global University, 558, Handong-ro, Heunghae-eup, Buk-gu, Pohang-si, Gyeongsangbuk-do, Republic of Korea
Gwanggyo
Address. 404, Ace Gwanggyo Tower 3, 77, Changnyong-daero 256-gil, Yeongtong-gu, Suwon-si, Gyeonggi-do, Republic of Korea
(C) 2022.HEM Pharma Inc. All rights reserved.